Table of Content - Global Factor VIII Deficiency Treatment Market

Hemophilia is usually an inherited bleeding disorder in which the blood does not clot properly. This may result in both spontaneous bleeding and bleeding after injuries or surgery. Blood contains a variety of clotting proteins that can aid in stopping bleeding. People with hemophilia have low levels of either factor VIII (8) or factor IX (9). The quantity of factors in a person's blood determines the severity of their hemophilia. The likelihood of bleeding, which can cause serious health issues, increases as the amount of the factor decreases. Hemophilia is caused by a mutation or change, in one of the genes, that provides instructions for making the clotting factor proteins needed to form a blood clot. This change or mutation can prevent the clotting protein from working properly or be missing altogether

Market Dynamics

Increase in the government and non-government organizations initiatives to improve access to affordable hemophilia treatment options. Rising incidences and prevalence of hemophilic disorder are expected to boost the growth of the market over the forecast period which leads to product launches in the market by the key players, to fulfill the unmet need of the market. Favorable regulatory scenarios and guidelines for product launches and treatment are other leading factors that are expected to propel the growth of the market over the forecast period. An increase in the research and development activities by key market players to develop novel hemophilia treatment options is further expected to drive market growth for the forecast period. For instance, on April 4, 2023, Sanofi S.A., a multinational pharmaceutical and healthcare company, announced the positive result of their phase-III clinical trials using fitusiran, a drug candidate used to treat hemophilia-A in adults.

Key features of the study:

This report provides in-depth analysis of the Global factor VIII deficiency treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new Product Type launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global factor VIII deficiency treatment market based on the following parameters – company highlights, Product Types portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter, Biogen, Inc., Bayer AG, CSL Behring, Ferring B.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Kedrion, and Novo Nordisk A/S
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product type launches, type up-gradation, market expansion, and marketing tactics
The Global factor VIII deficiency treatment market report caters to various stakeholders in this industry including investors, suppliers, product type manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global factor VIII deficiency treatment market

Detailed Segmentation:

Global Factor VIII Deficiency Treatment Market, By Product Type:
- Plasma Derived Coagulation Factor Concentrates
- Recombinant Coagulation Factor Concentrates
- Biologic (Hemlibra)
- Desmopressin
Global Factor VIII Deficiency Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Factor VIII Deficiency Treatment Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country:
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- Baxter*
  - Company Highlights
  - Product Types Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Biogen, Inc.
- Bayer AG
- CSL Behring
- Ferring B.V.
- F. Hoffmann-La Roche AG
- Pfizer, Inc.
- Kedrion
- Novo Nordisk A/S

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product Type
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Key Developments
- Recent Product Type Launches/Approvals
- Epidemiology
- Merger, Acquisition, Collaborations Scenario
- Regulatory Scenario
- PEST Analysis
- Porter's Five Forces Analysis
- Pricing Analysis
- Brand Analysis
Global Factor VIII Deficiency Treatment Market - Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
Global Factor VIII Deficiency Treatment Market, By Product Type, 2020 – 2032, (US$ Million)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Plasma Derived Coagulation Factor Concentrates
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Recombinant Coagulation Factor Concentrates
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Biologic (Hemlibra)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Desmopressin
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Global Factor VIII Deficiency Treatment Market, By Distribution Channel, 2020 – 2032, (US$ Million)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 – 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Global Factor VIII Deficiency Treatment Market, By Region, 2020 – 2032, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, For Regions, 2021–2032
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - China
    - Japan
    - India
    - Australia
    - ASEAN
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Baxter
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Biogen, Inc.
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CSL Behring
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ferring B.V.
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche AG
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Kedrion
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novo Nordisk A/S
  - Company Highlights
  - Product Type Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 25 market data tables and 25 figures on “Global Factor VIII Deficiency Treatment Market” - forecast to 2032

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE